Search

Your search keyword '"Jiang, Dongxian"' showing total 64 results

Search Constraints

Start Over You searched for: Author "Jiang, Dongxian" Remove constraint Author: "Jiang, Dongxian" Database Unpaywall Remove constraint Database: Unpaywall
64 results on '"Jiang, Dongxian"'

Search Results

1. ASO Visual Abstract: Development and Validation of PET/CT-Based Nomogram for Preoperative Prediction of Lymph Node Status in Esophageal Squamous Cell Carcinoma

4. Proteomic characterization of the colorectal cancer response to chemoradiation and targeted therapies reveals potential therapeutic strategies

6. Neoadjuvant Immunotherapy combined with Chemoradiotherapy VS. Neoadjuvant Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma(cStageII-III): A Multi-center Prospective Randomized Clinical Trial

7. Comprehensive proteogenomic characterization of early duodenal cancer reveals the carcinogenesis tracks of different subtypes

8. Integrative proteogenomic characterization of early esophageal cancer

10. Distribution of residual tumors in esophageal squamous cell carcinoma after neoadjuvant PD-1 blockade combined with chemotherapy

11. Proteogenomics of diffuse gliomas reveal molecular subtypes associated with specific therapeutic targets and immune-evasion mechanisms

13. Author Correction: Proteomic characterization of gastric cancer response to chemotherapy and targeted therapy reveals potential therapeutic strategies

14. Proteomic characterization of gastric cancer response to chemotherapy and targeted therapy reveals potential therapeutic strategies

17. The efficacy of additional surgical resection after endoscopic resection in pT1b esophageal squamous cell carcinoma: A multi-institutional retrospective study in China

18. Proteomic analysis reveals key differences between squamous cell carcinomas and adenocarcinomas across multiple tissues

20. Dual block HER2 assessment increased HER2 immunohistochemistry positive rate in resected specimens of gastric cancer: a prospective multicenter clinical trial from China

24. Which will carry more weight when CTR > 0.5, solid component size, CTR, tumor size or SUVmax?

28. Integrative proteogenomic characterization of early esophageal cancer

29. Dual Block HER2 Assessment Increased HER2 Immunohistochemistry Positive Rate in Resected Specimens of Gastric Cancer: A Prospective Multicenter Clinical Trial From China

32. Prognostic value and characterization of NTRK1 variation by fluorescence in situ hybridization in esophageal squamous cell carcinoma

34. CDK4 Amplification in Esophageal Squamous Cell Carcinoma Associated With Better Patient Outcome

35. Integrative proteogenomic characterization of early esophageal cancer

36. The efficacy of current-used risk factors for metastasis and the effectiveness of additional surgical resection in pT1b esophageal squamous cell carcinoma after endoscopic resection: A multi-institutional retrospective study in China

44. Late stage gastric cancer patients with extra gained HER2 positivity by dual block assessment may not show compromised efficacy to trastuzumab treatment

47. Poor prognostic impact of FGF4 amplification in patients with esophageal squamous cell carcinoma

50. HER2 assessment in locally advanced gastric cancer: comparing the results obtained with the use of two primary tumour blocks versus those obtained with the use of all primary tumour blocks

Catalog

Books, media, physical & digital resources